StockClub

PHAR

PHARPharming Group N.V.$ --
Pharming Group N.V.

Pharming Group N.V.

PHAR

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
106M USD
YoY +14.8%
Operating Income
2M USD
YoY -70.2%
Net Income
5M USD
YoY +85.2%
EPS
0.08$
YoY +66.7%

Revenue

$376M
FY2024 Q1$55.6M
$55.6M
Q1
FY2024 Q2$129.6M
$129.6M
Q2
FY2024 Q3$204.5M
$204.5M
Q3
FY2024 Q4$297.1M
$297.1M
Q4
FY2025 Q1$79.1M
$79.1M
Q1
FY2025 Q2$172.3M
$172.3M
Q2
FY2025 Q3$269.6M
$269.6M
Q3
FY2025 Q4$376M
$376M
Q4
Actual
+$78.9M (+26.5%)

Net Income

$2.8M
FY2024 Q1$-12.4M
$-12.4M
Q1
FY2024 Q2$-13.6M
$-13.6M
Q2
FY2024 Q3$-14.7M
$-14.7M
Q3
FY2024 Q4$-11.8M
$-11.8M
Q4
FY2025 Q1$-14.7M
$-14.7M
Q1
FY2025 Q2$-10M
$-10M
Q2
FY2025 Q3$-2.5M
$-2.5M
Q3
FY2025 Q4$2.8M
$2.8M
Q4
Actual
+$14.6M (+123.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:EUR212.2M
Est:EUR270.9M
FY2020MISS
EUR212.2M
FY2021MISS
Actual:EUR198.9M
Est:EUR253.5M
FY2021MISS
EUR198.9M
FY2022MISS
Actual:EUR205.6M
Est:EUR228.4M
FY2022MISS
EUR205.6M
FY2023MISS
Actual:EUR245.3M
Est:EUR266.4M
FY2023MISS
EUR245.3M
FY2024BEAT
Actual:EUR297.2M
Est:EUR286.4M
FY2024BEAT
EUR297.2M
FY2025MISS
Actual:EUR377.2M
Est:EUR387.8M
FY2025MISS
EUR377.2M

Analyst Estimates